Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Taipei Exchange - Delayed Quote TWD

Level Biotechnology Inc. (3118.TWO)

Compare
31.35
-0.30
(-0.95%)
At close: 1:30:02 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Yihan Li Accounting Supervisor -- -- --

Level Biotechnology Inc.

No. 80, Kangning Street
Lane 169 Xizhi District
New Taipei City, 221
Taiwan
886 2 2695 9935 https://www.level.com.tw
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
132

Description

Level Biotechnology Inc. engages in marketing and distributing cell culture, immunology, and molecular biology products in Taiwan. It also markets and distributes biomedical precision equipment. In addition, the company provides services in the areas of mammalian and genetic toxicology, pharmacology, biocompatibility, and model animal production. Further, it offers preclinical research services to the biotech, pharmaceutical, medical device, animal health, and agrichemical industries. The company was founded in 1989 and is headquartered in New Taipei City, Taiwan.

Corporate Governance

Level Biotechnology Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

June 18, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers